Cargando…
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
BACKGROUND: The effectiveness of long-acting injectable antipsychotics (LAIAs) has been demonstrated in studies using prescription claims data. However, the validity of claims data for LAIAs has not been established. OBJECTIVE: We aimed to validate date dispensed, quantity dispensed and days supplie...
Autores principales: | Janzen, Donica, Ramkissoon, Reece, Bolton, James M., Leong, Christine, Kuo, I fan, Alessi-Severini, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392671/ https://www.ncbi.nlm.nih.gov/pubmed/35578100 http://dx.doi.org/10.1007/s40801-022-00297-4 |
Ejemplares similares
-
Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort
por: Janzen, Donica, et al.
Publicado: (2022) -
Risk of long-term benzodiazepine and Z-drug use following the first prescription among community-dwelling adults with anxiety/mood and sleep disorders: a retrospective cohort study
por: Brandt, Jaden, et al.
Publicado: (2021) -
Prescription trends of antiseizure medications before and during the COVID-19 pandemic
por: Lavu, Alekhya, et al.
Publicado: (2023) -
Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
por: Voss, Erica A., et al.
Publicado: (2015) -
Treatment Adherence with Early Prescription of Long-Acting Injectable Antipsychotics in Recent-Onset Schizophrenia
por: Viala, Annie, et al.
Publicado: (2012)